Prevalence of cardiovascular risk factors, diseases set to increase
Jun 06, 2024
The annual inflation-adjusted health care costs of cardiovascular risk factors is projected to triple between 2020 and 2050.
Statins reduce CVD risk in adults aged 75 to 85 and 85 years and older
May 28, 2024
A risk reduction was seen for overall cardiovascular disease incidence for initiating statin therapy in both intention-to-treat and per-protocol analyses.
Fish oil beneficial for reducing risk for cardiovascular disease progression
May 22, 2024
However, supplements may be a risk factor for atrial fibrillation and stroke in the general population.
Physical activity time, step counts yield similar results
May 21, 2024
Similar benefits were seen for all-cause mortality and cardiovascular disease prevention.
Advocacy group alleges PDGM is ‘discriminatory’ policy
By
Diane Eastabrook
Mar 05, 2021
The Center for Medicare Advocacy (CMA) accused the Centers for Medicare and Medicaid Services (CMS) on Thursday of using unfair practices against beneficiaries requiring longer-term home healthcare.
Senators formulate plan to address chronic illness in Medicare beneficiaries
By
Lois A. Bowers
Oct 30, 2016
Improving health outcomes and reducing Medicare costs related to beneficiaries with chronic conditions such as Alzheimer’s disease, diabetes and heart disease are the goals of a bipartisan proposal...
Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
New CDC profile shares demographics of assisted living residents
By
Kimberly Bonvissuto
Sep 22, 2021
Bathing, walking and dressing are the most common activities of daily living that residents of assisted living or similar residential communities need help with, according to a new data brief from the...
Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
Report: Alzheimer’s is costliest disease in United States
By
Lois A. Bowers
Apr 04, 2016
A new report from the Alzheimer’s Association provides updated information on the current and predicted prevalence and cost of Alzheimer’s disease.